Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004970088 | SCV005539381 | uncertain significance | Inborn genetic diseases | 2024-07-14 | criteria provided, single submitter | clinical testing | The c.2266A>G (p.T756A) alteration is located in exon 12 (coding exon 12) of the BMPR2 gene. This alteration results from a A to G substitution at nucleotide position 2266, causing the threonine (T) at amino acid position 756 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005023758 | SCV005654592 | uncertain significance | Pulmonary hypertension, primary, 1; Pulmonary venoocclusive disease 1 | 2024-01-13 | criteria provided, single submitter | clinical testing |